glp-1 gip and glucagon Simplified summary of the biological actions of as The dual glucose-dependent insulinotropic polypeptide

Brand-name offers the most clinical evidence and regulatory oversight

Lixisenatide: Gastrointestinal : acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists under-going elective surgeries or procedures requiring general anesthesia or deep sedation

Persistent vomiting, inability to keep fluids down, severe abdominal pain, or extreme fatigue are not normal and should be evaluated

Encourage lifestyle optimization : Sleep, stress management, nutrition quality Support cofactors : Ensure adequate selenium, B vitamins, vitamin C Monitor response : Track subjective improvements (energy, recovery, cognition) and objective markers Adjust as needed : Unlimited consultations to ensure patients benefit from glutathione protocol or to make any adjustments as needed